Thursday, January 6, 2022

< + > An Interview With The Team Leader For The Scientific Discovery Of Pfizer’s COVID-19 Drug, Paxlovid

In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.

No comments:

Post a Comment

< + > It’s Time for “Actioning Information” to Move Past Interoperability’s Endless Data

The following is a guest article by E ffie Carlson, CEO at Watershed Health The Problem Is Not Only Data Availability, It’s What We Do Wi...